Literature DB >> 27186405

HPV E6/p53 mediated down-regulation of miR-34a inhibits Warburg effect through targeting LDHA in cervical cancer.

Rong Zhang1, Jing Su2, Song-Lin Xue3, Hui Yang2, Li-Li Ju1, Ying Ji1, Kai-Hua Wu1, Yan-Wei Zhang1, Ye-Xin Zhang4, Jian-Fang Hu2, Min-Min Yu1.   

Abstract

MicroRNAs (miRNA) play crucial roles in regulating cell proliferation, differentiation and developmental timing. Aberrantly expressed miRNAs have recently emerged as key regulators of metabolism. However, little is known about its role in tumor metabolism of cervical cancer. In this study, we determined the oncogenic effects of miRNAs on Warburg effect, a metabolic phenotype that allows cancer cells to utilize glucose even under aerobic conditions. A gain-of-function study was performed in 12 down-regulated miRNAs that frequently reported in cervical cancer. We found that miR-34a plays a suppressive role in Warburg effect as evidenced by decreased lactate production and glucose consumption. Knockdown of oncoprotein E6 expression of human papillomavirus in SiHa and HeLa cells by siRNAs lead to an increased protein level of p53, decreased level of miR-34a, as well as reduced Warburg effect. Subsequently, lactate dehydrogenase A (LDHA), which catalyzes the last key step in glycolysis, was identified as a direct target of miR-34a. Silencing of LDHA or introduction of miR-34a significantly attenuated colony formation ability and invasive capacity of SiHa and HeLa cells, and these effects were fully compromised by reintroduction of LDHA. In conclusion, our findings demonstrated that deregulated miR-34a/LDHA axis induced by HPV E6/p53 signaling facilitates tumor growth and invasion through regulating Warburg effect in cervical cancer, and provided new insights into the mechanism by which miR-34a contributes to the development and progression of cervical cancer.

Entities:  

Keywords:  Human papillomavirus; LDHA; Warburg effect; cervical cancer; miR-34a

Year:  2016        PMID: 27186405      PMCID: PMC4859662     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  36 in total

1.  Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

Authors:  Benjamin P Lewis; Christopher B Burge; David P Bartel
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

2.  Knockdown of lactate dehydrogenase A suppresses tumor growth and metastasis of human hepatocellular carcinoma.

Authors:  Shi L Sheng; Jian J Liu; Yun H Dai; Xiao G Sun; Xiao P Xiong; Gang Huang
Journal:  FEBS J       Date:  2012-09-13       Impact factor: 5.542

3.  Antitumour activity of an inhibitor of miR-34a in liver cancer with β-catenin-mutations.

Authors:  Angélique Gougelet; Chiara Sartor; Laura Bachelot; Cécile Godard; Carmen Marchiol; Gilles Renault; Frédéric Tores; Patrick Nitschke; Catherine Cavard; Benoit Terris; Christine Perret; Sabine Colnot
Journal:  Gut       Date:  2015-03-19       Impact factor: 23.059

4.  Attenuation of LDHA expression in cancer cells leads to redox-dependent alterations in cytoskeletal structure and cell migration.

Authors:  Robert Arseneault; Andrew Chien; Jordan T Newington; Tim Rappon; Richard Harris; Robert C Cumming
Journal:  Cancer Lett       Date:  2013-04-11       Impact factor: 8.679

5.  LDHA is necessary for the tumorigenicity of esophageal squamous cell carcinoma.

Authors:  Feng Yao; Tiejun Zhao; Chenxi Zhong; Ji Zhu; Heng Zhao
Journal:  Tumour Biol       Date:  2012-09-08

Review 6.  Role of microRNAs in the Warburg effect and mitochondrial metabolism in cancer.

Authors:  Li-Hui Jin; Chen Wei
Journal:  Asian Pac J Cancer Prev       Date:  2014

7.  The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44.

Authors:  Can Liu; Kevin Kelnar; Bigang Liu; Xin Chen; Tammy Calhoun-Davis; Hangwen Li; Lubna Patrawala; Hong Yan; Collene Jeter; Sofia Honorio; Jason F Wiggins; Andreas G Bader; Randy Fagin; David Brown; Dean G Tang
Journal:  Nat Med       Date:  2011-01-16       Impact factor: 53.440

8.  Sirt7 promotes gastric cancer growth and inhibits apoptosis by epigenetically inhibiting miR-34a.

Authors:  Shun Zhang; Ping Chen; Zuoan Huang; Xiaorong Hu; Mengting Chen; Shanshan Hu; Yixin Hu; Ting Cai
Journal:  Sci Rep       Date:  2015-04-10       Impact factor: 4.379

9.  MiR-125a suppresses tumor growth, invasion and metastasis in cervical cancer by targeting STAT3.

Authors:  Zhongyi Fan; Hanzhi Cui; Xiaojie Xu; Zhi Lin; Xuelin Zhang; Lei Kang; Baiyu Han; Jing Meng; Zhifeng Yan; Xiang Yan; Shunchang Jiao
Journal:  Oncotarget       Date:  2015-09-22

Review 10.  miR-34: from bench to bedside.

Authors:  Massimiliano Agostini; Richard A Knight
Journal:  Oncotarget       Date:  2014-02-28
View more
  36 in total

1.  [Over-expression of miR-519d alters gene expression profiles of cervical cancer SiHa cells].

Authors:  Ye Zeng; Jie Liu; Zhichao Cheng; Sirong Zheng; Hanrong Zhang; Jueyu Zhou
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-07-30

2.  Collagen prolyl 4-hydroxylase 2 predicts worse prognosis and promotes glycolysis in cervical cancer.

Authors:  Qingxian Li; Qingying Wang; Qinyi Zhang; Jing Zhang; Jiawen Zhang
Journal:  Am J Transl Res       Date:  2019-11-15       Impact factor: 4.060

3.  MicroRNA-497 regulates cisplatin chemosensitivity of cervical cancer by targeting transketolase.

Authors:  Hui Yang; Xiao-Li Wu; Kai-Hua Wu; Rong Zhang; Li-Li Ju; Ying Ji; Yan-Wei Zhang; Song-Lin Xue; Ye-Xin Zhang; Yong-Feng Yang; Min-Min Yu
Journal:  Am J Cancer Res       Date:  2016-11-01       Impact factor: 6.166

4.  Synergistic anti-tumor effect of anti-PD-L1 antibody cationic microbubbles for delivery of the miR-34a gene combined with ultrasound on cervical carcinoma.

Authors:  Yun Liu; Jinjun Jiang; Chaoqi Liu; Wensi Zhao; Yao Ma; Zhiwei Zheng; Qing Zhou; Yun Zhao
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

Review 5.  Glycolysis in the progression of pancreatic cancer.

Authors:  Xinyao Chang; Xingchen Liu; Haoze Wang; Xuan Yang; Yan Gu
Journal:  Am J Cancer Res       Date:  2022-02-15       Impact factor: 6.166

Review 6.  The comprehensive landscape of miR-34a in cancer research.

Authors:  Sijing Li; Xiaohui Wei; Jinyong He; Quanquan Cao; Danyu Du; Xiaoman Zhan; Yuqi Zeng; Shengtao Yuan; Li Sun
Journal:  Cancer Metastasis Rev       Date:  2021-05-06       Impact factor: 9.264

7.  Inhibiting Glucose Metabolism By miR-34a and miR-125b Protects Against Hyperglycemia-Induced Cardiomyocyte Cell Death.

Authors:  Chao-Rui Xu; Qiu-Ju Fang
Journal:  Arq Bras Cardiol       Date:  2021-03       Impact factor: 2.000

8.  Inhibition of lncRNA-NEAT1 sensitizes 5-Fu resistant cervical cancer cells through de-repressing the microRNA-34a/LDHA axis.

Authors:  Xuecheng Shao; Xuehui Zheng; Dan Ma; Yang Liu; Guoyan Liu
Journal:  Biosci Rep       Date:  2021-07-30       Impact factor: 3.840

9.  MiR-375 Is Epigenetically Downregulated by HPV-16 E6 Mediated DNMT1 Upregulation and Modulates EMT of Cervical Cancer Cells by Suppressing lncRNA MALAT1.

Authors:  Shikai Liu; Lili Song; Hairong Yao; Liang Zhang; Dongkui Xu; Fangyuan Gao; Qian Li
Journal:  PLoS One       Date:  2016-09-22       Impact factor: 3.240

Review 10.  The Glycolytic Switch in Tumors: How Many Players Are Involved?

Authors:  Li Yu; Xun Chen; Xueqi Sun; Liantang Wang; Shangwu Chen
Journal:  J Cancer       Date:  2017-09-20       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.